Navigation Links
Vaccine Pipeline Database: 1-Year Subscription
Date:10/6/2011

NEW YORK, Oct. 6, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Vaccine Pipeline Database: 1-Year Subscription

http://www.reportlinker.com/p0652031/Vaccine-Pipeline-Database-1-Year-Subscription.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

Product description

Subscription to La Merie's proprietary Vaccine Pipeline Database provides online access to more than 1,200 project entries for prophylactic and therapeutic vaccines on the market and in research & development. Each project is specified for its Target or Mechanism of Action, Therapeutic Area and R&D Phase. Use of the R&D database of vaccines is intuitive. Data sets of interest can be printed and exported. Projects are being updated continuously. The R&D history of each project with online references of information sources can be viewed and printed. The projects can be segmented into Territories, Therapeutic Areas and R&D Phases. An advanced search function allows to combine search parameters. A scroll down menu for predefined targets conveniently selects projects of interest. By clicking on column heads of the project list, projects can be arranged in ascending or descending alphabetical or numerical order, e.g. for phase, product category or company name. Sample screenshots illustrate the database.

Purchase of the subscription provides a 1-year online access to the data of the Antibody Pipeline Database. Credentials to access the database will be sent by e-mail within 24 hours after purchase.

Benefits from the Antibody Pipeline Database:

-New database (since 2008) with no historical burden

-Intuitive use

-Designed for structured searches

-Focused on targets, therapeutic areas and R&D phases

-Ideal for competitor analysis (companies, targets, product categories)

-Cost-effective and rapid solution for benchmarking

-Identification of licensing candidates

Project listing in a tabular format:

-Drug Codes

-Target / Mechanism of Action

-Class of Compound

-Product Category

-Company

-Territory

-Therapeutic Area

-Indication

-R&D Phase

Therapeutic Areas:

Cardiovascular & blood

Dermatology

Gastrointestinal

Genitourinary, renal & gynecology

Infectious & toxicology

Metabolism & endocrine

Neurology & psychiatry

Oncology

Ophthalmology & otorhinolaryngology

Orthopedics, dental, anesthesia & surgery

Pulmonary & respiratory

Rheumatoid & autoimmune

Examples of Predefined Targets of the Scroll Down Menu:

Hepatitis Vaccines

Influenza Vaccines

Herpes Virus Vaccines

Staphylococcal Aureus Vaccines

Streptococcal Vaccines

Pseudomonas Aeruginosa Vaccines

Cytomegalovirus (CMV) Vaccines

Tuberculosis Vaccines

Anthrax Vaccines

Respiratory Syncytial Virus (RSV) Vaccines

Human Papilloma Virus (HPV) Vaccines

Malaria Vaccines

Dengue Virus Vaccines

Human Immunodeficiency Virus (HIV) Vaccines

Therapeutic Cancer Vaccines

To order this report:

Drug and Medication Industry: Vaccine Pipeline Database: 1-Year Subscription

Drug and Medication Business News

More  Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
2. Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies
3. Synthetic Genomics Vaccines, Inc. Hires Vaccine Executive Sammy J. Farah as President
4. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
5. Nations Pharmacists Ready to Administer Seasonal Flu Vaccines
6. GlycoVaxyns Staphylococcus aureus Bioconjugate Vaccine Candidate Protects Mice Against Invasive S. aureus Infection
7. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
8. Initial Trial of Sanarias Malaria Vaccine Yields Positive Results
9. Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing
10. Anthem Blue Cross Kicks Off Statewide Series Of Free Whooping Cough Vaccine Clinics In Watts On Saturday
11. Pevion Grants CSL Option Right to its Therapeutic Candida Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... December 2, 2016 According ... Diagnostics/IVD Market by Product (Instruments, Reagents, Software), Technology ... Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast to ... valued at USD 60.22 Billion in 2016. This ... of 5.5% during the forecast period (2016-2021) to ...
(Date:12/2/2016)... 2, 2016  The Addiction Treatment Advisory Group ... Managed Care Pharmacy (AMCP), has released detailed findings ... the opioid addiction crisis, including through improved access ... ATAG,s newly released paper, "The Role of ... addresses many issues around gaps and barriers to ...
(Date:12/2/2016)... , Dec. 2, 2016 Boston Scientific ... definitive agreement to acquire certain manufacturing assets and capabilities ... (TSX: NVC) advanced biological tissue business, as well as ... of $75 million in cash. The Neovasc advanced biological ... including the Boston Scientific Lotus™ Valve System. * ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... 2016 , ... More than 100 business, civic, community and ... the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, hosted by ... support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, Stillman College ...
(Date:12/2/2016)... ... December 02, 2016 , ... U.S. Surgeon General, Dr. Vivek Murthy, graces the ... how he was inspired to practice medicine at an early age by his father, ... than making diagnoses and prescribing medicine,” he states. “It is about building relationships with ...
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet is proud to ... which covers the innovative treatments, therapeutic technologies, and revolutionized nutrition that are helping ... prolonging life 6 years in the last 3 decades,” says Dr. Valentine Fuster, ...
(Date:12/2/2016)... ... 02, 2016 , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique ... other wearable health technology on the market can deliver all that rejiva can. , ... insights about their health than the usual heart rate and steps taken”, adds Evens ...
(Date:12/2/2016)... , ... December 02, 2016 , ... ... organizations to build intelligent, connected applications, was named the best Sales Team of ... The winner announcement was made today by the Software & Information Industry Association ...
Breaking Medicine News(10 mins):